EQS: latest releases

• Biotest unveiled functional data from its new Factor VIII compounds at the ISTH 2020 congress (International Society on Thrombosis and Haemostasis).
• Results from further animal models support a 4-fold extension of the half-life in blood circulation while maintaining the wild-type characteristics of activated Factor VIII with full in vivo functionality.
• These benefits are based on the fusion of special Factor VIII sequences with four albumin-binding peptides shielding the active substance from degradation.
• The ordinary and preference shares of Biotest AG are listed in the Prime Standard on the German stock exchange.

• Northern Data's partnership with Gigabyte covers the production, supply and combination of components, where Northern Data tests specific processors (GPUs, CPUs, etc.)
• In doing so, Gigabyte adjusts the GPU clusters developed by Northern Data to meet all of Northern Data's technical requirements.
• And Thomas Yen, European head of Gigabyte Technologies explains: "We are pleased to now officially announce our partnership with Northern Data.
• Gigabyte Technology Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and sales of information technology (IT) products.

• Hamburg, Germany, 21 July 2020: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that the Company has entered into a comprehensive partnership with the recently established QUANTRO Therapeutics GmbH ("QUANTRO"), a research-based biotech company based in Vienna, Austria, that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programmes in cancer and other diseases.
• By introducing "Transcriptional Fingerprinting" to drug discovery, QUANTRO intends to revamp the scope of pharmacologic interventions in a variety of cellular, target and disease contexts.
• Both companies have acquired equal minority stakes in QUANTRO and will be represented on QUANTRO's Supervisory Board by Dr Dirk Ullmann (Evotec) and Dr Sebastian Kreuz (BIVF), respectively.
• QUANTRO Therapeutics ("QUANTRO") is a research-based entity that strives to discover and develop novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases.

• Vienna, Austria, 21 July 2020: QUANTRO Therapeutics GmbH today announced that the company has established its operations with seed financing from Boehringer Ingelheim Venture Fund (BIVF) and Evotec.
• As a research-based company, QUANTRO will combine and exploit innovative functional genetics and transcriptomics technologies to generate an unprecedented drug discovery pipeline transforming the precision and scope of cell-based compound screens.
• By introducing 'Transcriptional Fingerprinting' to drug discovery, QUANTRO intends to revamp the scope of pharmacologic interventions in a variety of cellular, target and disease contexts.
• Dr. Dieter Nachtigall, Chief Executive Officer of QUANTRO, said: "QUANTRO Therapeutics has designed and set up a new discovery approach and technology platform based on world-leading scientific expertise by our founders and excellent support from our highly committed corporate venture partners.

• Mogo Finance and its group companies (the "Group"), specialized in used car financing, cordially invites investors and analysts to a conference call with the Management Board on 29 July 2020, 16:00 CET, following the publication of its unaudited 6M 2020 results on 27 July 2020.
• CEO Modestas Sudnius and CFO Maris Kreics will present and comment on the unaudited results by means of a presentation.
• Mogo Finance is one of the largest and fastest-growing secured used car financing companies in Europe.
• Mogo Finance operates through its own branch network, more than 1,800 partner locations and strong online presence.

• Kaufman & Broad's Board of Directors met on Friday, July 17, 2020.
• It noted that Promogim Groupe SAS declared that it held 13.41% of the share capital, which is close to the stake held by Kaufman & Broad's management and employees.
• In this context, the Board of Directors wishes to inform Kaufman & Broad's shareholders of the unsolicited and uncoordinated nature of this initiative, which also raises an issue of conflicts of interest given the nature of the activity of Promogim, a residential developer in direct competition with Kaufman & Broad.
• The Board therefore denounces a creeping takeover attempt at a value that does not in any way reflect Kaufman & Broad's fundamentals and is therefore totally contrary to the interests of all of its shareholders.

• Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
• The issuer is solely responsible for the content of this announcement.
• This announcement contains price sensitive information.
• As at the close of business on 30 June 2020, the unaudited cum-dividend net asset value of the Company's Ordinary Shares was 104.08p.

Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

• For details, please refer to the Announcement on the Proposed Registration and Issuance of Debt Financing Instruments of Haier Smart Home Co., Ltd.
• : L2020-019) and the Announcement of Resolutions at the 2019 Annual General Meeting of Shareholders of Haier Smart Home Co.,Ltd.
• : L2020-033), which was disclosed on the website of Shanghai Stock Exchange and relevant websites by the Company on 16 July 2020.
• On 17 July 2020, the Company issued the first tranche of super short-term commercial papers of 2020 pursuant to the funding arrangement of the Company and the conditions of the inter-bank market, and the information of the issuance are as follows:
  The first tranche of super short-term commercial papers of 2020 of Haier Smart Home Co.,Ltd.

• Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
• If none, this should be stated.

• Form 8.3 - Baader Bank AG: PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
  Dissemination of a Regulatory Announcement, transmitted by EQS Group.
• The issuer is solely responsible for the content of this announcement.
• (b)Owner or controller of interests and short positions disclosed, if different from 1(a):
  The naming of nominee or vehicle companies is insufficient.
• (f)In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

Chelverton UK Dividend Trust plc: Net Asset Value(s)
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
The Net Asset Value (NAV) at 17/07/2020 was:
Number of shares in issue:

• London, 20 July 2020 - MBH Corporation plc (MBH), a diversified investment holding company, today announces the successful listing of the MBH Bond 2020/25 (WKN: A28ZQU / ISIN: XS2193852261).
• Furthermore, MBH has listed a EUR bond with a coupon of 2% (WKN: A28ZQS / ISIN: XS2193851701) which is also traded in the Frankfurt Stock Exchange.
• MBH Corporation plc is a diversified investment holding company, listed on the Frankfurt and Dusseldorf Stock Exchanges.
• By leveraging the Agglomeration strategy, MBH Corporation plc is able to create substantial shareholder value through the consistent, accretive acquisition of excellent companies.

• About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
• Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
• Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
• Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

• Tele Columbus, one of Germany's leading fibreglass network operators, has further improved the customer service of its PUR brand despite the coronavirus pandemic.
• This was made possible by systematically improving the quality of the products and services, and by expanding the digital service channels for customers.
• The higher NPS score - the established standard for measuring customer satisfaction in service companies - rose again quite significantly.
• Tele Columbus AG is one of Germany's leading fibre network operators which reaches more than 3 million homes.

• Successful premiere: EQS Group has held the first fully virtual Annual General Meeting in Germany where shareholders were able to exercise all of their rights online.
• Shareholders not only had the opportunity to vote online but could also participate in the general debate with questions and comments.
• These were however hybrid AGMs with virtual and on-site participation running in parallel as fully virtual AGMs were not permitted under German public company law.
• In the first three quarters of 2020, EQS Group will, according to current expectations, support a total of around 50 AGMs as a technical service provider.